Trials / Completed

CompletedNCT00002085

A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: —

Sponsor: Pfizer · Industry
Sex: All
Age: 1 Day
Healthy volunteers: Not accepted

Summary

To evaluate the efficacy and safety of azithromycin given chronically for the treatment of serious nontuberculous mycobacterial infection in patients failing or intolerant of other available therapy.

Conditions

Mycobacterium Avium-Intracellulare Infection
HIV Infections
Tuberculosis, Mycobacterium Infection

Interventions

Type	Name	Description
DRUG	Azithromycin

Timeline

First posted: 2001-08-31
Last updated: 2005-06-24

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00002085. Inclusion in this directory is not an endorsement.